Abstract

Depression and anxiety often coexist during pregnancy, potentially increasing the risk of adverse delivery outcomes like preterm birth and low birth weight. However, our understanding of the frequency, patterns, and factors influencing comorbid anxiety and depression is limited, especially in low- and middle-income countries. This study aims to: (1) explore the prevalence and patterns of prenatal anxiety and depressive symptoms among pregnant women in the mild-to-severe and moderate-to-severe categories; (2) examine the prevalence and patterns of antenatal anxiety and depressive symptoms among pregnant women in the mild-to-severe category; (3) investigate the association between frequent folic acid use and prenatal anxiety and depression symptoms. The study adopted a retrospective cohort approach and enrolled a diverse sample of 500 pregnant women receiving care at the Women and Children’s Hospital in various locations across the center and south of Iraq. Results indicated that women who did not consume folic acid during pregnancy exhibited higher rates of comorbid anxiety and depression. Specifically, this pattern was observed among women in the age range of 20 to 29 years, those with a university degree, and those who had more than two previous children.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call